Health

Imec.xpand has returned for a $16m series B round that will allow Spectricity to accelerate the development of its sensors and imagers.

Lilly Asia Ventures was among the participants in a series C round closed by the Ant Group and China Re-backed healthcare payment platform operator.

CRRC Times and Xiamen Xiangyu were among the LPs for the venture firm’s latest dollar vehicle that will invest in healtech companies concentrating on biotech, IVDs and medical supplies.

Alameda Research, Blockchain.com and Coinbase helped cryptocurrency exchange Pintu close a $35m round while small molecule drug developer Aardvark raised $29m.

The Adimab and GV-backed covid-19 antibody treatment developer has floated on Nasdaq at a $1.84bn valuation, about a year after it was founded.

Cigna Ventures returned to back an $83.5m round for the kidney care provider that also featured new investor Blue Shield of California.

University of Oxford’s genetic therapeutics spinout has secured the crossover funding eight months after a series A round also backed by OSI.

SoftBank’s Vision Fund returned to back the e-commerce business in a $1bn round. Our data suggest upward pressure on valuations in this space as well.

The Angelini Lumira Biosciences Fund will invest in early-stage companies in Canada and the US.

JD Health has backed a $93m series D round for Rimag, while a couple of India-based startups delivered exits.

The China Union-backed drug contract manufacturer has raised the funding approximately a year and a half after a $60m series A.